168 related articles for article (PubMed ID: 21695734)
1. Cannabinoid type 1 receptor gene polymorphisms are not associated with olanzapine-induced weight gain.
Park YM; Choi JE; Kang SG; Koo SH; Kim L; Geum D; Lee HJ
Hum Psychopharmacol; 2011; 26(4-5):332-7. PubMed ID: 21695734
[TBL] [Abstract][Full Text] [Related]
2. Leptin and leptin receptor gene polymorphisms and increases in body mass index (BMI) from olanzapine treatment in persons with schizophrenia.
Ellingrod VL; Bishop JR; Moline J; Lin YC; Miller DD
Psychopharmacol Bull; 2007; 40(1):57-62. PubMed ID: 17285096
[TBL] [Abstract][Full Text] [Related]
3. Pilot study of the G-protein beta3 subunit gene (C825T) polymorphism and clinical response to olanzapine or olanzapine-related weight gain in persons with schizophrenia.
Bishop JR; Ellingrod VL; Moline J; Miller D
Med Sci Monit; 2006 Feb; 12(2):BR47-50. PubMed ID: 16449941
[TBL] [Abstract][Full Text] [Related]
4. Weight gain associated with the alpha2a-adrenergic receptor -1,291 C/G polymorphism and olanzapine treatment.
Park YM; Chung YC; Lee SH; Lee KJ; Kim H; Byun YC; Lim SW; Paik JW; Lee HJ
Am J Med Genet B Neuropsychiatr Genet; 2006 Jun; 141B(4):394-7. PubMed ID: 16583406
[TBL] [Abstract][Full Text] [Related]
5. Pharmacogenomic associations with weight gain in olanzapine treatment of patients without schizophrenia.
Houston JP; Kohler J; Bishop JR; Ellingrod VL; Ostbye KM; Zhao F; Conley RR; Poole Hoffmann V; Fijal BA
J Clin Psychiatry; 2012 Aug; 73(8):1077-86. PubMed ID: 22967772
[TBL] [Abstract][Full Text] [Related]
6. Association of a functional polymorphism in neuropeptide Y with antipsychotic-induced weight gain in schizophrenia patients.
Tiwari AK; Brandl EJ; Weber C; Likhodi O; Zai CC; Hahn MK; Lieberman JA; Meltzer HY; Kennedy JL; Müller DJ
J Clin Psychopharmacol; 2013 Feb; 33(1):11-7. PubMed ID: 23277265
[TBL] [Abstract][Full Text] [Related]
7. Lack of association between the -759C/T polymorphism of the 5-HT2C receptor gene and olanzapine-induced weight gain among Korean schizophrenic patients.
Park YM; Cho JH; Kang SG; Choi JE; Lee SH; Kim L; Lee HJ
J Clin Pharm Ther; 2008 Feb; 33(1):55-60. PubMed ID: 18211617
[TBL] [Abstract][Full Text] [Related]
8. A common polymorphism in the cannabinoid receptor 1 (CNR1) gene is associated with antipsychotic-induced weight gain in Schizophrenia.
Tiwari AK; Zai CC; Likhodi O; Lisker A; Singh D; Souza RP; Batra P; Zaidi SH; Chen S; Liu F; Puls I; Meltzer HY; Lieberman JA; Kennedy JL; Müller DJ
Neuropsychopharmacology; 2010 May; 35(6):1315-24. PubMed ID: 20107430
[TBL] [Abstract][Full Text] [Related]
9. Multiple genetic factors in olanzapine-induced weight gain in schizophrenia patients: a cohort study.
Ujike H; Nomura A; Morita Y; Morio A; Okahisa Y; Kotaka T; Kodama M; Ishihara T; Kuroda S
J Clin Psychiatry; 2008 Sep; 69(9):1416-22. PubMed ID: 19193342
[TBL] [Abstract][Full Text] [Related]
10. HTR2C polymorphisms, olanzapine-induced weight gain and antipsychotic-induced metabolic syndrome in schizophrenia patients: a meta-analysis.
Ma X; Maimaitirexiati T; Zhang R; Gui X; Zhang W; Xu G; Hu G
Int J Psychiatry Clin Pract; 2014 Oct; 18(4):229-42. PubMed ID: 25152019
[TBL] [Abstract][Full Text] [Related]
11. A hypothesis-driven association study of 28 nuclear-encoded mitochondrial genes with antipsychotic-induced weight gain in schizophrenia.
Gonçalves VF; Zai CC; Tiwari AK; Brandl EJ; Derkach A; Meltzer HY; Lieberman JA; Müller DJ; Sun L; Kennedy JL
Neuropsychopharmacology; 2014 May; 39(6):1347-54. PubMed ID: 24196945
[TBL] [Abstract][Full Text] [Related]
12. Protein kinase cAMP-dependent regulatory type II beta (PRKAR2B) gene variants in antipsychotic-induced weight gain.
Gagliano SA; Tiwari AK; Freeman N; Lieberman JA; Meltzer HY; Kennedy JL; Knight J; Müller DJ
Hum Psychopharmacol; 2014 Jul; 29(4):330-5. PubMed ID: 24737441
[TBL] [Abstract][Full Text] [Related]
13. Endocannabinoid Pro129Thr FAAH functional polymorphism but not 1359G/A CNR1 polymorphism is associated with antipsychotic-induced weight gain.
Monteleone P; Milano W; Petrella C; Canestrelli B; Maj M
J Clin Psychopharmacol; 2010 Aug; 30(4):441-5. PubMed ID: 20631561
[TBL] [Abstract][Full Text] [Related]
14. Long-term weight gain in patients treated with open-label olanzapine in combination with fluoxetine for major depressive disorder.
Andersen SW; Clemow DB; Corya SA
J Clin Psychiatry; 2005 Nov; 66(11):1468-76. PubMed ID: 16420086
[TBL] [Abstract][Full Text] [Related]
15. Possible association between the -2548A/G polymorphism of the leptin gene and olanzapine-induced weight gain.
Kang SG; Lee HJ; Park YM; Choi JE; Han C; Kim YK; Kim SH; Lee MS; Joe SH; Jung IK; Kim L
Prog Neuropsychopharmacol Biol Psychiatry; 2008 Jan; 32(1):160-3. PubMed ID: 17804136
[TBL] [Abstract][Full Text] [Related]
16. Olanzapine-induced weight gain plays a key role in the potential cardiovascular risk: evidence from heart rate variability analysis.
Wang J; Liu YS; Zhu WX; Zhang FQ; Zhou ZH
Sci Rep; 2014 Dec; 4():7394. PubMed ID: 25487560
[TBL] [Abstract][Full Text] [Related]
17. A2BP1 gene polymorphisms association with olanzapine-induced weight gain.
Dong L; Yan H; Huang X; Hu X; Yang Y; Ma C; Du B; Lu T; Jin C; Wang L; Yu H; Dong Z; Li W; Ruan Y; Zhang H; Zhang H; Mi W; Ma W; Li K; Lv L; Zhang D; Yue W
Pharmacol Res; 2015 Sep; 99():155-61. PubMed ID: 26092620
[TBL] [Abstract][Full Text] [Related]
18. Association study of olanzapine-induced weight gain and therapeutic response with SERT gene polymorphisms in female schizophrenic patients.
Bozina N; Medved V; Kuzman MR; Sain I; Sertic J
J Psychopharmacol; 2007 Sep; 21(7):728-34. PubMed ID: 17092963
[TBL] [Abstract][Full Text] [Related]
19. Association study of brain-derived neurotrophic factor gene polymorphisms and body weight change in schizophrenic patients under long-term atypical antipsychotic treatment.
Tsai A; Liou YJ; Hong CJ; Wu CL; Tsai SJ; Bai YM
Neuromolecular Med; 2011 Dec; 13(4):328-33. PubMed ID: 21956459
[TBL] [Abstract][Full Text] [Related]
20. Polymorphisms of the 5-HT2C receptor and leptin genes are associated with antipsychotic drug-induced weight gain in Caucasian subjects with a first-episode psychosis.
Templeman LA; Reynolds GP; Arranz B; San L
Pharmacogenet Genomics; 2005 Apr; 15(4):195-200. PubMed ID: 15864111
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
